- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
How should hormone therapy for castration-resistant prostate cancer be continued? - Abstract
February 17, 2012
Patterns of care for brachytherapy in Europe: Updated results for Spain - Abstract
February 16, 2012
Developing a laparoscopic radical prostatectomy service: Defining the learning curve - Abstract
February 16, 2012
Cholesterol and the risk of grade-specific prostate cancer incidence: Evidence from two large prospective cohort studies with up to 37 years' follow up - Abstract
February 16, 2012
Recovery of urinary function after radical prostatectomy: Predictors of urinary function on preoperative prostate magnetic resonance imaging - Abstract
February 15, 2012
GU Cancers Symposium 2012 - Active surveillance vs. watchful waiting for localized prostate cancer
February 15, 2012
Nerve mapping for prostatectomies: Novel technologies under development - Abstract
February 14, 2012
Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer - Abstract
February 10, 2012
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia - Abstract
February 10, 2012
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review - Abstract
February 10, 2012
Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values? - Abstract
February 10, 2012
WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights
February 10, 2012
WCE 2011 - Human versus robot: Who can perform more accurate prostate biopsy? - Session Highlights
February 10, 2012
The emerging role of diffusion-weighted MRI in prostate cancer management - Abstract
February 9, 2012